FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Magí Farré

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Yolanda Alvarez; Clara Pérez-Mañá; Marta Torrens; Magí Farré
Antipsychotic drugs in cocaine dependence: A systematic review and meta-analysis.
Elia Torrent; Alba Ruiz; Ibane Abasolo; Magí Farré; Gispert Juan; Jordi Llop; Olga Millan; Deborah Pareto
Optimization of [11C]Raclopride Positron Emission Tomographic Rat Studies: Comparison of Methods for Image Quantification.
Rosa Ventura; R Bergés; Lucia M P Damasceno; Magí Farré; Rosalía Ramírez; Jordi Segura
Evaluation of the urinary threshold concentration of formoterol in sports drug testing.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Magí Farré (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yolanda Alvarez; Clara Pérez-Mañá; Marta Torrens; Magí Farré
Antipsychotic drugs in cocaine dependence: A systematic review and meta-analysis.
Journal of substance abuse treatment 2013;45(1):1-10.
2013: Elia Torrent; Alba Ruiz; Ibane Abasolo; Magí Farré; Gispert Juan; Jordi Llop; Olga Millan; Deborah Pareto
Optimization of [11C]Raclopride Positron Emission Tomographic Rat Studies: Comparison of Methods for Image Quantification.
Molecular imaging 2013;12(4):257-62.
2013: Rosa Ventura; R Bergés; Lucia M P Damasceno; Magí Farré; Rosalía Ramírez; Jordi Segura
Evaluation of the urinary threshold concentration of formoterol in sports drug testing.
Drug testing and analysis 2013;5(4):266-9.
2013: Emilia Marchei; Roberta Pacifici; Esther Papaseit; Amaia Bilbao; Magí Farré; Oscar Garcia-Algar; Simona Pichini
Sweat testing for the detection of atomoxetine from paediatric patients with attention deficit/ hyperactivity disorder: application to clinical practice.
Drug testing and analysis 2013;5(3):191-5.
2013: Ana M Peiró; Mitona Pujadas; Pere N Roset; Marta Torrens; Jordi Camí; M Carbó; Magí Farré; Rafael de la Torre
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart.
Psychopharmacology 2013;225(4):883-93.
2013: Albert Batalla; Sagnik Bhattacharyya; Jose Alexandre Crippa; Magí Farré; Paolo Fusar-Poli; Santiago Nogué; Jesús Pujol; Marta Torrens; Murat Yucel; Rocio Martin-Santos
Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.
PloS one 2013;8(2):e55821.
2012: Clara Pérez-Mañá; Carola Llonch; Magí Farré
[Transparency in clinical research: registration of clinical trials and publication of results].
Medicina clínica 2012;139(13):593-7.
2012: Jaume Miranda; Pere Roset; Lluís Brunet; Magí Farré; Carlos Mendieta
Reliability of two measurement indices for gingival enlargement.
Journal of periodontal research 2012;47(6):776-82.
2012: Esther Papaseit; Clara Pérez-Mañá; Mitona Pujadas; Antonia Vázquez; Rafael de la Torre; Magí Farré; Joan Nolla
Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV).
Intensive care medicine 2012;38(7):1239-40.
2012: Fernando Caudevilla-Gálligo; Magí Farré; Débora González; Jordi Riba; Mireia Ventura; Manel J Barbanoj; José Carlos Bouso
4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects.
Journal of psychopharmacology (Oxford, England) 2012;26(7):1026-35.
2012: Mónica Giménez; Marina López-Solà; Joan Deus; Magí Farré; Emilio Merlo Pich; Hector Ortiz; Jesús Pujol; Carles Soriano-Mas; Rocio Martín-Santos
Altered brain functional connectivity in relation to perception of scrutiny in social anxiety disorder.
Psychiatry research 2012;202(3):214-23.
2012: Bruno Almeida Cotrim; Miguel Romero Cuevas; Juan Manuel Decara del Olmo; Magí Farré; Montserrat Fitó; Jesús Joglar; Manuel Macias-González; Daniel Muñoz-Aguayo; M Jesús L Rojas; Fernando Rodríguez de Fonseca; María Isabel Covas Planells; Rafael de la Torre
Unsaturated fatty alcohol derivatives of olive oil phenolic compounds with potential low-density lipoprotein (LDL) antioxidant and antiobesity properties.
Journal of agricultural and food chemistry 2012;60(4):1067-74.
2012: Rafael de la Torre; Ricardo Pardo-Lozano; Samanta Yubero-Lahoz; Magí Farré
MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?
Frontiers in genetics 2012;3():235.
2012: Ricardo Pardo-Lozano; Clara Pérez-Mañá; Marta Torrens; Samanta Yubero-Lahoz; Magí Farré; Klaus Langohr; Cristina Mustata; Brian O'Mathúna; Marcel lí Carbó; Elisabet Cuyàs; Rafael de la Torre
Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT).
PloS one 2012;7(10):e47599.
2012: José A G Agúndez; Raúl J Andrade; Lina Badimon; Jaime Del Barrio; Magí Farré; Elena García-Martín; Teresa Padró; Camilla Stephens; Gemma Vilahur; M Isabel Lucena
Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology.
Frontiers in pharmacology 2012;3():2.
2011: Santiago Bullich; Magí Farré; Gispert Juan; Roger Gunn; Antonio Gutiérrez; Raul Herance; Lawrence S Kegeles; Jong-Hoon Kim; Marc Laruelle; N Venkatesha Murthy; Jan Passchier; Mark Slifstein; Xiaoyan Xu; Ana M Catafau
Biodistribution and radiation dosimetry of the glycine transporter-1 ligand 11C-GSK931145 determined from primate and human whole-body PET.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2011;13(4):776-84.
2011: Samanta Yubero-Lahoz; Ricardo Pardo; Magí Farré; Brian O'Mahony; Marta Torrens; Cristina Mustata; Clara Pérez-Mañá; Marcel Lí Carbó; Rafael de la Torre
Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans.
Clinical pharmacokinetics 2011;50(5):319-29.
2011: Elisabet Cuyàs; Aida Cuenca; Susana de Sola Llopis; Ana Beatriz Fagundo; Magí Farré; Olha Khymenets; Klaus Langohr; Rocío Martín-Santos; Jordi Peña-Casanova; Joan Rodríguez; Marta Torrens; Antonio Verdejo-García; Rafael de la Torre
The influence of genetic and environmental factors among MDMA users in cognitive performance.
PloS one 2011;6(11):e27206.
2011: Francina Fonseca; Rafael de la Torre; Laura Díaz; Antonio Pastor; Elisabet Cuyàs; Nieves Pizarro; Olha Khymenets; Magí Farré; Marta Torrens
Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response.
PloS one 2011;6(5):e19527.
2011: Jimena Fiz; Marta Durán; Dolors Capellà; Jordi Carbonell; Magí Farré
Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life.
PloS one 2011;6(4):e18440.
2011: Fabrizio Schifano; Stefano D'Offizi; Michele Piccione; Ornella Corazza; Paolo Deluca; Zoe Davey; Giuditta Di Melchiorre; Lucia Di Furia; Magí Farré; Liv Flesland; Miia Mannonen; Aino Majava; Stefania Pagani; Teuvo Peltoniemi; Holger Siemann; Arvid Skutle; Marta Torrens; Cinzia Pezzolesi; Peer van der Kreeft; Norbert Scherbaum
Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data.
Psychotherapy and psychosomatics 2011;80(2):118-22.
2010: Marta Duran; Eulàlia Pérez; Sergio Abanades; Xavier Vidal; Cristina Saura; Margarita Majem; Edurne Arriola; Manel Rabanal; Antoni Pastor; Magí Farré; Neus Rams; Joan-Ramon Laporte; Dolors Capellà
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.
British journal of clinical pharmacology 2010;70(5):656-63.
2010: Bruno Almeida; Jesús Joglar; María Jesús Luque Rojas; Juan Manuel Decara; Francisco Javier Bermúdez-Silva; Manuel Macias-González; Montserrat Fitó; Miguel Romero-Cuevas; Magí Farré; María Isabel Covas; Fernando Rodríguez de Fonseca; Rafael de la Torre
Synthesis of fatty acid amides of catechol metabolites that exhibit antiobesity properties.
ChemMedChem 2010;5(10):1781-7.
2010: Olha Khymenets; Montserrat Fitó; Sonia Touriño; Daniel Muñoz-Aguayo; Mitona Pujadas; Josep Lluis Torres; Jesús Joglar; Magí Farré; María-Isabel Covas; Rafael de la Torre
Antioxidant activities of hydroxytyrosol main metabolites do not contribute to beneficial health effects after olive oil ingestion.
Drug metabolism and disposition: the biological fate of chemicals 2010;38(9):1417-21.
2010: Ana B Fagundo; Elisabet Cuyàs; Antonio Verdejo-Garcia; Olha Khymenets; Klaus Langohr; Rocío Martín-Santos; Magí Farré; Rafael de la Torre
The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users.
Journal of psychopharmacology (Oxford, England) 2010;24(9):1381-93.
2010: Emilia Marchei; Magí Farré; Ricardo Pardo; Oscar Garcia-Algar; Manuela Pellegrini; Roberta Pacifici; Simona Pichini
Usefulness of sweat testing for the detection of methylphenidate after fast- and extended-release drug administration: a pilot study.
Therapeutic drug monitoring 2010;32(4):508-11.
2010: Simona Pichini; Magí Farré; Sergio Abanades; Roberta Pacifici; Piergiorgio Zuccaro; Klaus Langohr; Rafael de la Torre
Immunomodulating properties of gamma-hydroxybutyrate (GHB), flunitrazepam and ethanol in 'club drugs' users.
Addiction biology 2010;15(3):336-45.
2010: Juan José Torrado; María Blanco; Magí Farré; Pere Roset; Alfredo García-Arieta
Rationale and conditions for the requirement of chiral bioanalytical methods in bioequivalence studies.
European journal of clinical pharmacology 2010;66(6):599-604.
2010: Emilia Marchei; Magí Farré; Ricardo Pardo; Oscar Garcia-Algar; Manuela Pellegrini; Roberta Pacifici; Simona Pichini
Correlation between methylphenidate and ritalinic acid concentrations in oral fluid and plasma.
Clinical chemistry 2010;56(4):585-92.
2010: Elisabet Cuyàs; Estibaliz Olano-Martín; Olha Khymenets; Lorena Hernández; Laia Jofre-Monseny; Laura Grandoso; Diego Tejedor; Antonio Martínez; Magí Farré; Rafael de la Torre
Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchip.
Pharmacogenomics 2010;11(2):257-66.
2010: Rocío Martín-Santos; Marta Torrens; Sandra Poudevida; Klaus Langohr; Elisabet Cuyás; Roberta Pacifici; Magí Farré; Simona Pichini; Rafael de la Torre
5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.
Addiction biology 2010;15(1):15-22.
2010: Yolanda Alvarez; Magí Farré; Francina Fonseca; Marta Torrens
Anticonvulsant drugs in cocaine dependence: a systematic review and meta-analysis.
Journal of substance abuse treatment 2010;38(1):66-73.
2009: Helmut Schröder; Rafael de la Torre; Ramón Estruch; Dolores Corella; Miguel Angel Martínez-González; Jordi Salas-Salvadó; Emilio Ros; Fernando Arós; Gemma Flores; Ester Civit; Magí Farré; Miguel Fiol; Joan Vila; Joaquín Fernandez-Crehuet; Valentina Ruiz-Gutiérrez; Jose Lapetra; Guillermo T Sáez; María-Isabel Covas
Alcohol consumption is associated with high concentrations of urinary hydroxytyrosol.
The American journal of clinical nutrition 2009;90(5):1329-35.
2009: Valentini Konstantinidou; Olha Khymenets; María-Isabel Covas; Rafael de la Torre; Daniel Muñoz-Aguayo; Roger Anglada; Magí Farré; Montserrat Fito
Time course of changes in the expression of insulin sensitivity-related genes after an acute load of virgin olive oil.
Omics : a journal of integrative biology 2009;13(5):431-8.
2009: Ximena Perfetti; Brian O'Mathúna; Nieves Pizarro; Elisabet Cuyàs; Olha Khymenets; Bruno Almeida; Manuela Pellegrini; Simona Pichini; Serrine S Lau; Terrence J Monks; Magí Farré; Jose Antonio Pascual; Jesús Joglar; Rafael de la Torre
Neurotoxic thioether adducts of 3,4-methylenedioxymethamphetamine identified in human urine after ecstasy ingestion.
Drug metabolism and disposition: the biological fate of chemicals 2009;37(7):1448-55.
2009: Simona Pichini; Esther Papaseit; Xavier Joya; Oriol Vall; Magí Farré; Oscar Garcia-Algar; Rafael de laTorre
Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics.
Therapeutic drug monitoring 2009;31(3):283-318.
2009: Olha Khymenets; Montserrat Fitó; María-Isabel Covas; Magí Farré; Maria-Antonia Pujadas; Daniel Muñoz; Valentini Konstantinidou; Rafael de la Torre
Mononuclear cell transcriptome response after sustained virgin olive oil consumption in humans: an exploratory nutrigenomics study.
Omics : a journal of integrative biology 2009;13(1):7-19.
2009: Francina Fonseca; Julio Marti-Almor; Antoni Pastor; Mercè Cladellas; Magí Farré; Rafael de la Torre; Marta Torrens
Prevalence of long QTc interval in methadone maintenance patients.
Drug and alcohol dependence 2009;99(1-3):327-32.
2008: Antonio Requena; Julio Herrero; José Landeras; Esperanza Navarro; José L Neyro; Cristina Salvador; Rosa Tur; Justo Callejo; Miguel A Checa; Magí Farré; Juan J Espinós; Francesc Fábregues; María Graña-Barcia
Use of letrozole in assisted reproduction: a systematic review and meta-analysis.
Human reproduction update 2008;14(6):571-82.
2008: Olha Khymenets; Maria Isabel Covas; Magí Farré; Klaus Langohr; Montserrat Fitó; Rafael de la Torre
Role of sex and time of blood sampling in SOD1 and SOD2 expression variability.
Clinical biochemistry 2008;41(16-17):1348-54.
2008: Brian O'Mathúna; Magí Farré; Amin Rostami-Hodjegan; Jiansong Yang; Elisabet Cuyàs; Marta Torrens; Ricardo Pardo; Sergio Abanades; Silvana Maluf; Geoffrey T Tucker; Rafael de la Torre
The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans.
Journal of clinical psychopharmacology 2008;28(5):523-9.
2008: Susana Torrado; Meritxell Roig; Magí Farré; Jordi Segura; Rosa Ventura
Urinary metabolic profile of 19-norsteroids in humans: glucuronide and sulphate conjugates after oral administration of 19-nor-4-androstenediol.
Rapid communications in mass spectrometry : RCM 2008;22(19):3035-42.
2008: Susana de Sola; Thais Tarancón; Jordi Peña-Casanova; Josep María Espadaler; Klaus Langohr; Sandra Poudevida; Magí Farré; Antonio Verdejo-García; Rafael de la Torre
Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study.
Psychopharmacology 2008;200(3):425-37.
2008: José Carlos Bouso; Rick Doblin; Magí Farré; Miguel Angel Alcázar; Gregorio Gómez-Jarabo
MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.
Journal of psychoactive drugs 2008;40(3):225-36.
2008: Susana Torrado; Jordi Segura; Magí Farré; Rosa Ventura
Gas chromatography-mass spectrometry method for the analysis of 19-nor-4-androstenediol and metabolites in human plasma: application to pharmacokinetic studies after oral administration of a prohormone supplement.
Steroids 2008;73(7):751-9.
2008: Simona Pichini; Mitona Pujadas; Emilia Marchei; Manuela Pellegrini; Jimena Fiz; Roberta Pacifici; Piergiorgio Zuccaro; Magí Farré; Rafael de la Torre
Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers.
Journal of pharmaceutical and biomedical analysis 2008;47(2):335-42.
2008: Ana M Catafau; Santiago Bullich; Mónica Danús; María M Penengo; Albert Cot; Sergio Abanades; Magí Farré; Javier Pavía; Domènec Ros
Test-retest variability and reliability of 123I-IBZM SPECT measurement of striatal dopamine D2 receptor availability in healthy volunteers and influence of iterative reconstruction algorithms.
Synapse (New York, N.Y.) 2008;62(1):62-9.
2008: Ana Macedo; Josep-E Baños; Magí Farré
Placebo response in the prophylaxis of migraine: a meta-analysis.
European journal of pain (London, England) 2008;12(1):68-75.
2007: Sergio Abanades; Magí Farré; Diego Barral; Marta Torrens; Neus Closas; Klaus Langohr; Antoni Pastor; Rafael de la Torre
Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
Journal of clinical psychopharmacology 2007;27(6):625-38.
2007: Magí Farré; Sergio Abanades; Pere N Roset; Ana M Peiró; Marta Torrens; Bryan O'Mathúna; Mireia Segura; Rafael de la Torre
Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.
The Journal of pharmacology and experimental therapeutics 2007;323(3):954-62.
2007: Roberta Pacifici; Piergiorgio Zuccaro; Magí Farré; Sandra Poudevida; Sergio Abanades; Simona Pichini; Klaus Langohr; Jordi Segura; Rafael de la Torre
Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans.
Addiction (Abingdon, England) 2007;102(6):931-6.
2007: Sergio Abanades; Magí Farré; Mireia Segura; Simona Pichini; Antoni Pastor; Roberta Pacifici; Manuela Pellegrini; Rafael de la Torre
Disposition of gamma-hydroxybutyric acid in conventional and nonconventional biologic fluids after single drug administration: issues in methodology and drug monitoring.
Therapeutic drug monitoring 2007;29(1):64-70.
2006: Jiansong Yang; M Jamei; Amir Heydari; Karen Rowland Yeo; Rafael de la Torre; Magí Farré; Geoffrey T Tucker; Amin Rostami-Hodjegan
Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA.
Journal of psychopharmacology (Oxford, England) 2006;20(6):842-9.
2006: Sergio Abanades; Magí Farré; Mireia Segura; Simona Pichini; Diego Barral; Roberta Pacifici; Manuela Pellegrini; Francina Fonseca; Klaus Langohr; Rafael de la Torre
Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.
Annals of the New York Academy of Sciences 2006;1074():559-76.
2006: Rafael de la Torre; María-Isabel Covas; Maria Antonia Pujadas; Montserrat Fitó; Magí Farré
Is dopamine behind the health benefits of red wine?
European journal of nutrition 2006;45(5):307-10.
2006: Marta Duran; Sergio Abanades; Magí Farré; Dolors Capellà
[Cannabinoids and emesis: new evidences, new questions].
Medicina clínica 2006;127(6):237-8; author reply 238.
2006: Sergio Abanades; A Cabrero-Castel; Diego Barral; Y Alvarez; Magí Farré
[Other factors that condition the long-term toxicity of 3,4 methylenedioxymethamphetamine ('ecstasy')].
Revista de neurologia 2006;42(7):447; author reply 447-8.
2006: Ana Macedo; Magí Farré; Josep-E Baños
A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials.
European journal of clinical pharmacology 2006;62(3):161-72.
2006: Simona Pichini; Sandra Poudevida; Mitona Pujadas; Ester Menoyo; Roberta Pacifici; Magí Farré; Rafael de la Torre
Assessment of chronic exposure to MDMA in a group of consumers by segmental hair analysis.
Therapeutic drug monitoring 2006;28(1):106-9.
2005: Olha Khymenets; Jordi Ortuño; Montserrat Fitó; M A Isabel Covas; Magí Farré; Rafael de la Torre
Evaluation of RNA isolation procedures from human blood and its application for gene expression studies (Sod-1, Sod-2).
Analytical biochemistry 2005;347(1):156-8.
2005: Magí Farré; Ester Menoyo; J A Pascual; Pere N Roset; Sergio Abanades; Y Alvarez; A Baena
[Study of the extent and rate of bioavailability of ibuprofen tablets].
Reumatología clinica 2005;1(3):155-60.
2005: Rafael de la Torre; Magí Farré; Brian O Mathúna; Pere N Roset; Nieves Pizarro; Mireia Segura; Marta Torrens; Jordi Ortuño; Mitona Pujadas; Jordi Camí
MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers.
European journal of clinical pharmacology 2005;61(7):551-4.
2005: Y Alvarez; A Cabrero; Sergio Abanades; Magí Farré
[Metamphetamine].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2005;35(9):495-6.
2005: Marta Torrens; Francina Fonseca; Gerard Mateu; Magí Farré
Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.
Drug and alcohol dependence 2005;78(1):1-22.
2005: Jaume Miranda; Lluís Brunet; Pere Roset; Leonardo Berini; Magí Farré; Carlos Mendieta
Prevalence and risk of gingival overgrowth in patients treated with diltiazem or verapamil.
Journal of clinical periodontology 2005;32(3):294-8.
2005: Simona Pichini; Sergio Abanades; Magí Farré; Manuela Pellegrini; Emilia Marchei; Roberta Pacifici; Rafael de la Torre; Piergiorgio Zuccaro
Quantification of the plant-derived hallucinogen Salvinorin A in conventional and non-conventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking.
Rapid communications in mass spectrometry : RCM 2005;19(12):1649-56.
2005: Mireia Segura; Magí Farré; Simona Pichini; Ana M Peiró; Pere N Roset; Ariel Ramírez; Jordi Ortuño; Roberta Pacifici; Piergiorgio Zuccaro; Jordi Segura; Rafael de la Torre
Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe.
Clinical pharmacokinetics 2005;44(6):649-60.
2005: Sergio Abanades; C Unizony; Y Alvarez; Magí Farré
[Hallucinogenics: drugs for dreaming?].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2005;35(1):54.
2004: Sergio Abanades; Y Alvarez; C Unizony; Magí Farré
[More information on GHB].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 2004;34(10):568.
2004: Rafael de la Torre; Magí Farré
Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.
Trends in pharmacological sciences 2004;25(10):505-8.
2004: Sergio Abanades; Ana M Peiró; Magí Farré
[Club drugs: old medicines as new party drugs].
Medicina clínica 2004;123(8):305-11.
2004: Nieves Pizarro; Magí Farré; Mitona Pujadas; Ana M Peiró; Pere N Roset; Jesús Joglar; Rafael de la Torre
Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
Drug metabolism and disposition: the biological fate of chemicals 2004;32(9):1001-7.
2004: Jaume Marrugat; María-Isabel Covas; Montserrat Fitó; Helmut Schröder; Elisabet Miró-Casas; Eva Gimeno; M Carmen López-Sabater; Rafael de la Torre; Magí Farré
Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation--a randomized controlled trial.
European journal of nutrition 2004;43(3):140-7.
2004: Magí Farré; Rafael de la Torre; B O Mathúna; Pere N Roset; Ana M Peiró; Marta Torrens; Jordi Ortuño; Mitona Pujadas; Jordi Camí
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.
Psychopharmacology 2004;173(3-4):364-75.
2004: Jordi Ferreres; Josep-E Baños; Magí Farré
[Nocebo effect: the other side of placebo].
Medicina clínica 2004;122(13):511-6.
2004: Rafael de la Torre; Magí Farré; Pere N Roset; Nieves Pizarro; Sergio Abanades; Mireia Segura; Jordi Segura; Jordi Camí
Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.
Therapeutic drug monitoring 2004;26(2):137-44.
2004: Sergio Abanades; Juan Nolla; Ana Rodríguez-Campello; Carme Pedro; Antonio Valls; Magí Farré
Reversible coma secondary to cefepime neurotoxicity.
The Annals of pharmacotherapy 2004;38(4):606-8.
2004: Roberta Pacifici; Simona Pichini; Piergiorgio Zuccaro; Magí Farré; Mireia Segura; Jordi Ortuño; Simonetta Di Carlo; Antonella Bacosi; Pere N Roset; Jordi Segura; Rafael de la Torre
Paroxetine inhibits acute effects of 3,4-methylenedioxymethamphetamine on the immune system in humans.
The Journal of pharmacology and experimental therapeutics 2004;309(1):285-92.
2004: Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.
Clinical pharmacokinetics 2004;43(3):157-85.
2004: Magí Farré; Fèlix Bosch; Pere N Roset; Josep-E Baños
Putting clinical pharmacology in context: the use of popular movies.
Journal of clinical pharmacology 2004;44(1):30-6.
2003: Mitona Pujadas; Simona Pichini; Sandra Poudevida; Ester Menoyo; Piergiorgio Zuccaro; Magí Farré; Rafael de la Torre
Development and validation of a gas chromatography-mass spectrometry assay for hair analysis of amphetamine, methamphetamine and methylenedioxy derivatives.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;798(2):249-55.
2003: Jordi Camí; Magí Farré
Drug addiction.
The New England journal of medicine 2003;349(10):975-86.
2003: Ana Macedo; Magí Farré; Josep-E Baños
Placebo effect and placebos: what are we talking about? Some conceptual and historical considerations.
European journal of clinical pharmacology 2003;59(4):337-42.
2003: Simona Pichini; Monica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Jordi Ortuño; Magí Farré; Pere N Roset; Jordi Segura; Rafael de la Torre
Usefulness of sweat testing for the detection of MDMA after a single-dose administration.
Journal of analytical toxicology 2003;27(5):294-303.
2003: Sergio Abanades; Magí Farré
[Drug Design].
Medicina clínica 2003;121(1):38.
2003: Magí Farré; Marta Torrens
Maintenance buprenorphine for opioid users.
Lancet 2003;361(9372):1906-7; author reply 1907-8.
2003: Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini; Pere N Roset; Sandra Poudevida; Magí Farré; Jordi Segura; Rafael de la Torre
Modulation of the immune system in cannabis users.
JAMA : the journal of the American Medical Association 2003;289(15):1929-31.
2003: Mireia Segura; Jordi Ortuño; Magí Farré; Roberta Pacifici; Simona Pichini; Jesús Joglar; Jordi Segura; Rafael de la Torre
Quantitative determination of paroxetine and its 4-hydroxy-3-methoxy metabolite in plasma by high-performance liquid chromatography/electrospray ion trap mass spectrometry: application to pharmacokinetic studies.
Rapid communications in mass spectrometry : RCM 2003;17(13):1455-61.
2003: Nieves Pizarro; Amadeu Llebaria; Silvia Cano; Jesús Joglar; Magí Farré; Jordi Segura; Rafael de la Torre
Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry.
Rapid communications in mass spectrometry : RCM 2003;17(4):330-6.
2002: Roberta Pacifici; Piergiorgio Zuccaro; Magí Farré; Simona Pichini; Simonetta Di Carlo; Pere N Roset; Ilaria Palmi; Jordi Ortuño; Ester Menoyo; Jordi Segura; Rafael de la Torre
Cell-mediated immune response in MDMA users after repeated dose administration: studies in controlled versus noncontrolled settings.
Annals of the New York Academy of Sciences 2002;965():421-33.
2002: Mireia Segura; Jordi Ortuño; J A McLure; Mitona Pujadas; Nieves Pizarro; Magí Farré; Amadeu Llebaria; Jesús Joglar; Jordi Segura; Rafael de la Torre
High-performance liquid chromatography with electrochemical detection applied to the analysis of 3,4-dihydroxymethamphetamine in human plasma and urine.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2002;769(2):313-21.
2002: Nieves Pizarro; Jordi Ortuño; Magí Farré; Cándido Hernández-López; Mitona Pujadas; Amadeu Llebaria; Jesús Joglar; Pere N Roset; Marta Mas; Jordi Segura; Jordi Camí; Rafael de la Torre
Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
Journal of analytical toxicology 2002;26(3):157-65.
2002: Nieves Pizarro; Rafael de la Torre; Magí Farré; Jordi Segura; Amadeu Llebaria; Jesús Joglar
Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites.
Bioorganic & medicinal chemistry 2002;10(4):1085-92.
2002: Montserrat Fitó; Eva Gimeno; María-Isabel Covas; Elisabet Miró; Maria del Carmen López-Sabater; Magí Farré; la Torre Rafael de; Jaume Marrugat
Postprandial and short-term effects of dietary virgin olive oil on oxidant/antioxidant status.
Lipids 2002;37(3):245-51.
2002: Eva Gimeno; Montserrat Fitó; Rosa M Lamuela-Raventós; Ana I Castellote; María-Isabel Covas; Magí Farré; M Carmen de la Torre-Boronat; M Carmen López-Sabater
Effect of ingestion of virgin olive oil on human low-density lipoprotein composition.
European journal of clinical nutrition 2002;56(2):114-20.
2002: Magí Farré; Anna Mas; Marta Torrens; Victor Moreno; Jordi Camí
Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis.
Drug and alcohol dependence 2002;65(3):283-90.
2002: Cándido Hernández-López; Magí Farré; Pere N Roset; Ester Menoyo; Nieves Pizarro; Jordi Ortuño; Marta Torrens; Jordi Camí; Rafael de la Torre
3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.
The Journal of pharmacology and experimental therapeutics 2002;300(1):236-44.
2002: Simona Pichini; Mònica Navarro; Magí Farré; Jordi Ortuño; Pere N Roset; Roberta Pacifici; Piergiorgio Zuccaro; Jordi Segura; Rafael de la Torre
On-site testing of 3,4-methylenedioxymethamphetamine (ecstasy) in saliva with Drugwipe and Drugread: a controlled study in recreational users.
Clinical chemistry 2002;48(1):174-6.
2002: Shi Hua Peng; Jordi Segura; Magí Farré; Jose Carlos González; Xavier de la Torre
Plasma and urinary markers of oral testosterone undecanoate misuse.
Steroids 2002;67(1):39-50.
2001: Roberta Pacifici; Piergiorgio Zuccaro; Magí Farré; Simona Pichini; Simonetta Di Carlo; Pere N Roset; Jordi Ortuño; Mitona Pujadas; Antonella Bacosi; Ester Menoyo; Jordi Segura; Rafael de la Torre
Effects of repeated doses of MDMA ("ecstasy") on cell-mediated immune response in humans.
Life sciences 2001;69(24):2931-41.
2001: Pere N Roset; Magí Farré; Rafael de la Torre; Marta Mas; Ester Menoyo; C Hernández; Jordi Camí
Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males.
Drug and alcohol dependence 2001;64(3):285-98.
2001: M Navarro; S Pichini; Magí Farré; Jordi Ortuño; Pere N Roset; J Segura; Rafael de la Torre
Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH.
Clinical chemistry 2001;47(10):1788-95.
2001: María-Isabel Covas; Montserrat Fitó; Jaume Marrugat; E Miró; Magí Farré; Rafael de la Torre; Eva Gimeno; M Carmen López-Sabater; Rosa M Lamuela-Raventós; M Carmen de la Torre-Boronat
[Coronary disease protective factors: antioxidant effect of olive oil].
Thérapie 2001;56(5):607-11.
2001: Lluís Brunet; Jaume Miranda; Pere Roset; Leonardo Berini; Magí Farré; Carlos Mendieta
Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs.
European journal of clinical investigation 2001;31(9):781-8.
2001: Mireia Segura; Jordi Ortuño; Magí Farré; J A McLure; Mitona Pujadas; Nieves Pizarro; Amadeu Llebaria; Jesús Joglar; Pere N Roset; Jordi Segura; Rafael de la Torre
3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans.
Chemical research in toxicology 2001;14(9):1203-8.
2001: Jaume Miranda; Lluís Brunet; Pere Roset; Leonardo Berini; Magí Farré; Carlos Mendieta
Prevalence and risk of gingival enlargement in patients treated with nifedipine.
Journal of periodontology 2001;72(5):605-11.
2001: Roberta Pacifici; Magí Farré; Simona Pichini; Jordi Ortuño; Pere N Roset; Piergiorgio Zuccaro; Jordi Segura; Rafael de la Torre
Sweat testing of MDMA with the Drugwipe analytical device: a controlled study with two volunteers.
Journal of analytical toxicology 2001;25(2):144-6.
2001: Mireia Segura; J Barbosa; Marta Torrens; Magí Farré; Claudio Castillo; Jordi Segura; Rafael de la Torre
Analytical methodology for the detection of benzodiazepine consumption in opioid-dependent subjects.
Journal of analytical toxicology 2001;25(2):130-6.
2001: Roberta Pacifici; Piergiorgio Zuccaro; C Hernandez López; Simona Pichini; Simonetta Di Carlo; Magí Farré; Pere N Roset; Jordi Ortuño; Jordi Segura; R L Torre
Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans.
The Journal of pharmacology and experimental therapeutics 2001;296(1):207-15.
2000: Magí Farré; Pere N Roset; C H Lopez; Marta Mas; Jordi Ortuño; Ester Menoyo; Nieves Pizarro; Jordi Segura; J Cami
Pharmacology of MDMA in humans.
Annals of the New York Academy of Sciences 2000;914():225-37.
2000: Roberta Pacifici; Piergiorgio Zuccaro; Magí Farré; Simona Pichini; Simonetta Di Carlo; Pere N Roset; C H Lopez; Jordi Ortuño; Jordi Segura; Jordi Camí; Rafael de la Torre
Immunomodulating activity of MDMA.
Annals of the New York Academy of Sciences 2000;914():215-24.
2000: R Bergés; Jordi Segura; Rosa Ventura; Kenneth D Fitch; AR Morton; Magí Farré; Marta Mas; Xavier de la Torre
Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment.
Clinical chemistry 2000;46(9):1365-75.
2000: J Cami; Magí Farré; Marta Mas; Pere N Roset; Sandra Poudevida; A Mas; L San; Rafael de la Torre
Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects.
Journal of clinical psychopharmacology 2000;20(4):455-66.
2000: Shi Hua Peng; Jordi Segura; Magí Farré; Xavier de la Torre
Oral testosterone administration detected by testosterone glucuronidation measured in blood spots dried on filter paper.
Clinical chemistry 2000;46(4):515-22.
2000: Rafael de la Torre; Magí Farré; Jordi Ortuño; Marta Mas; R Brenneisen; Pere N Roset; Jordi Segura; Jordi Camí
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
British journal of clinical pharmacology 2000;49(2):104-9.
2000: Roberta Pacifici; Piergiorgio Zuccaro; Magí Farré; Simona Pichini; Simonetta Di Carlo; Pere N Roset; Jordi Ortuño; Jordi Segura; Cándido Hernández-López; Rafael de la Torre
[Immunomodulator properties of ecstasy (MDMA)].
Annali dell'Istituto superiore di sanità 2000;36(1):69-75.
1999: Nieves Pizarro; Jordi Ortuño; Jordi Segura; Magí Farré; Marta Mas; Jordi Camí; Rafael de la Torre
Quantification of amphetamine plasma concentrations by gas chromatography coupled to mass spectrometry.
Journal of pharmaceutical and biomedical analysis 1999;21(4):739-47.
1999: A Ràfols; J A García Vicente; Magí Farré; M Mas
[Dextromethorphan-induced sexual dysfunction].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 1999;24(8):495-7.
1999: Marta Mas; Magí Farré; Rafael de la Torre; Pere N Roset; Jordi Ortuño; J Segura; Jordi Camí
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.
The Journal of pharmacology and experimental therapeutics 1999;290(1):136-45.
1999: K Arasteh; Sandra Poudevida; Magí Farré; Pere N Roset; Jordi Camí
Response patterns of the Spanish version of the 49-item short form of the Addiction Research Center Inventory after the use of sedatives, stimulants, and opioids.
Drug and alcohol dependence 1999;55(1-2):117-25.
1999: Jordi Ortuño; Nieves Pizarro; Magí Farré; Marta Mas; Jordi Segura; Jordi Camí; R Brenneisen; Rafael de la Torre
Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection.
Journal of chromatography. B, Biomedical sciences and applications 1999;723(1-2):221-32.
1999: Rafael de la Torre; J Ortuño; M Mas; Magí Farré; J Segura
Fatal MDMA intoxication.
Lancet 1999;353(9152):593.
1999: Roberta Pacifici; Piergiorgio Zuccaro; Magí Farré; Simona Pichini; Simonetta Di Carlo; Pere N Roset; Jordi Ortuño; Jordi Segura; Rafael de la Torre
Immunomodulating properties of MDMA alone and in combination with alcohol: a pilot study.
Life sciences 1999;65(26):PL309-16.
1998: Magí Farré; MT Terán; Pere N Roset; Marta Mas; Marta Torrens; Jordi Camí
Abuse liability of flunitrazepam among methadone-maintained patients.
Psychopharmacology 1998;140(4):486-95.
1998: Marta Mas; Magí Farré; Pere N Roset; Jordi Camí
[Toxicity of ecstasy].
Medicina clínica 1998;111(13):516-7.
1998: Marta Mas; Pere N Roset; Magí Farré; Jordi Camí
Comment: use and abuse of flunitrazepam.
The Annals of pharmacotherapy 1998;32(9):980-1.
1998: Marta Mas; Sandra Poudevida; Magí Farré
[Commentaries on ecstasy].
Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria 1998;22(3):188-9.
1998: J Cami; Magí Farré; M L González; Jordi Segura; Rafael de la Torre
Cocaine metabolism in humans after use of alcohol. Clinical and research implications.
Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism 1998;14():437-55.
1997: Magí Farré; Rafael de la Torre; M L González; MT Terán; Pere N Roset; Ester Menoyo; Jordi Camí
Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism.
The Journal of pharmacology and experimental therapeutics 1997;283(1):164-76.
1997: Cristina Aguilera; Josep Maria Arnau; C Bosch; Josep-Maria Castel; Joan-Ramon Laporte; I Paredes; Antonio Vallano; Magí Farré; MT Terán; E Menoyo
[Analgesics in the postoperative period of abdominal interventions. The Study Group on Postoperative Analgesia of the Spanish Society of Clinical Pharmacology].
Medicina clínica 1997;108(4):136-40.
1996: Magí Farré; Pere N Roset
Long-term tacrine treatment in Alzheimer's disease.
Lancet 1996;348(9035):1181-2.
1996: Magí Farré; M T Terán; Jordi Camí
A comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers.
Psychopharmacology 1996;125(1):1-12.
1995: Magí Farré; X Lamas; Jordi Camí
Sensation seeking amongst healthy volunteers participating in phase I clinical trials.
British journal of clinical pharmacology 1995;39(4):405-9.
1995: Rafael de la Torre; J Ortuño; M L González; Magí Farré; Jordi Camí; Jordi Segura
Determination of cocaine and its metabolites in human urine by gas chromatography/mass spectrometry after simultaneous use of cocaine and ethanol.
Journal of pharmaceutical and biomedical analysis 1995;13(3):305-12.
1994: X Lamas; Magí Farré; Victor Moreno; Jordi Camí
Effects of morphine in postaddict humans: a meta-analysis.
Drug and alcohol dependence 1994;36(2):147-52.
1994: X Lamas; Magí Farré; M Llorente; Jordi Camí
Spanish version of the 49-item short form of the Addiction Research Center Inventory (ARCI).
Drug and alcohol dependence 1994;35(3):203-9.
1994: Jordi Camí; X Lamas; Magí Farré
Acute effects of tramadol in methadone-maintained volunteers.
Drugs 1994;47 Suppl 1():39-43.
1993: Magí Farré; Rafael de la Torre; M Llorente; X Lamas; B Ugena; Jordi Segura; Jordi Camí
Alcohol and cocaine interactions in humans.
The Journal of pharmacology and experimental therapeutics 1993;266(3):1364-73.
1993: Luis San; J Tato; Marta Torrens; Claudio Castillo; Magí Farré; Jordi Camí
Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification.
Drug and alcohol dependence 1993;32(3):281-6.
1992: Jordi Camí; Magí Farré; X Lamas
Volunteering for research.
Lancet 1992;340(8827):1103.
1992: Magí Farré; B Ugena; J M Badenas; M Márquez; Pere N Roset; J A Ortiz
Pharmacokinetics and tolerance of sertaconazole in man after repeated percutaneous administration.
Arzneimittel-Forschung 1992;42(5A):752-4.
1991: X Lamas; Magí Farré; M Llorente
[Drugs for the treatment of pain].
Medicina clínica 1991;96(5):195-6.
1987: Jordi Camí; J M Antó; J Monteis; F Alvarez-Lerma; E Menoyo; F Caus; Magí Farré
Monitoring cocaine epidemics in Barcelona.
Lancet 1987;2(8556):450-1.